ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Natural Bladder Control, Go Less and Live More

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Curcumin Reverses the Cellular Damage of Chronic Stress

Probiotics improve cognition in Alzheimer's patients

The Onion: Cancer Fighter and Food Preserver

 
Print Page
Email Article

Using Innovative Funding Mechanisms to Discover, Develop, and Test a Potentially Promising AD Drug

  [ Not Yet Rated ]   [ Discuss This Article ]
By 1999 Progress Report by the NIA/NIH • www.ProHealth.com • December 13, 1999


AIT-082 is a novel small molecule that crosses the blood-brain barrier to enhance nerve function. It does this by increasing the levels of nerve growth factors and encouraging nerve sprouting in the brain. The process that AIT-082 has gone through--from initial discovery to tests in humans--illustrates well the way in which NIA's innovative funding mechanisms work together to foster the development of potentially promising drug treatments for AD.

A Small Business Innovation Research Grant (SBIR) was the first NIH step for AIT-082. This grant allowed scientists to develop the compound and conduct initial tests on its function. Based on the promising results from this work, NIA provided funds through the Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease contract mechanism to begin the formal drug testing process. The studies showed that AIT-082 did not have an adverse toxicologic effect in laboratory animals. The National Institute of Mental Health also contributed to this effort by providing support through a contract to synthesize sufficient quantities of AIT-082 for the toxicologic testing.

These results allowed researchers to take the step from animal tests to tests in humans, and NIA is currently supporting Phase I clinical trials of AIT-082. In Phase 1 studies, a small number of volunteers are given a drug to assess safety at various doses and establish some initial indication of effectiveness. The studies have been conducted through the Alzheimer's Disease Cooperative Study at four Alzheimer's Disease Centers sites (the University of California at San Diego, Indiana University, the University of Michigan, and Washington University in St. Louis). In a Phase IA study, eight healthy older volunteers were given single, weekly, increasing doses of AIT-082 or a placebo for 5 weeks. During that time they were tested for side effects and for whether they properly absorbed the drug. They also underwent a battery of neuropsychological memory tests, including word and number recall tests. The study period is complete and the research team is now analyzing the results. A Phase IB study is currently ongoing in which safety and initial effectiveness is being assessed in 36 people with AD.

If the results show that AIT-082 is both safe and has some indication of effectiveness, the next step will be to test the drug in a larger clinical trial for its effect on AD symptoms, development, or progression.

Source:
National Institutes of Health
National Institute on Aging
1999 PROGRESS REPORT ON ALZHEIMER'S DISEAS



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Ultra ATP+, Double Strength Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
The Surprising Benefits of Probiotics - What You Didn't Know The Surprising Benefits of Probiotics - What You Didn't Know
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map